Schreiner Group relocates Chinese plant to Jinshan

Schreiner Group has finalized the relocation of its Chinese production plant from Fengpu to the 5,300 square meters facility in Jinshan. The move was part of the expansion strategy and a response to consistent growth in the region.

Schreiner Group has been present in China for the last eight years, however, the plant, which was initially established in Fengpu to supply customers from the automotive industry has since evolved into an established location for the healthcare industry as well.

The end of 2022 saw the relocation of Schreiner Group’s Chinese site within Shanghai from Fengpu to Jinshan. Whereas at the old location around 2,200 square meters of floor space were available the new location currently offers nearly 5,300 square meters.

The newly gained area had become urgently necessary due to the company’s constant growth. The new site has since become successfully established especially with production for the Chinese market because Schreiner Group’s success formula says: ‘local for local’.

‘Due to our local production, we can deliver products to our customers fast, reliably, and in our usual top quality,’ said CEO of the company Roland Schreiner. ‘As a result, we not only avoid long shipping routes and offer short delivery times but also show a presence on the Chinese market that’s not focused on exports. By pursuing this purpose, that element, just like our location in America, has clearly strengthened our entire group of companies.’

Another positive aspect is the fact that Jinshan is staffed almost exclusively by Chinese employees with high loyalty and retention to Schreiner Group.

Location manager Jamie Long recently celebrated his 15th anniversary of service to the company. In addition, the promotion of two Chinese colleagues to leadership roles is a visible sign that the company believes in its local employees and invests in them. That is an incentive for new employees as well because growth continues.

‘As a result of our move to Jinshan a little more than a year and a half ago, we have an area that’s almost three times as large as the one we had before—and that’s exactly the space we need for further growth,’ commented Thomas Köberlein, president of Schreiner ProTech and managing director of Schreiner Group China. ‘The Chinese domestic market is huge and offers plenty of potential in our core segments, Mobility and Healthcare. We’re in a good position locally with both Schreiner ProTech and Schreiner MediPharm and can therefore gradually expand our market position.’

The local production enables the development and manufacture directly on the ground, which not only strengthens the company’s global competitiveness but also its ties to the local markets. That is a significant element of Schreiner Group’s internationalization strategy, which has proven to be extremely successful.